D&A at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s D&A?
- MBX Biosciences, Inc. (MBX) reported D&A of $64K in Q1 2026.
- How has MBX Biosciences, Inc.'s D&A changed year-over-year?
- MBX Biosciences, Inc.'s D&A decreased by 16.9% year-over-year, from $77K to $64K.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.